PubMed

Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

Charbel Issa P, Finger RP, Holz FG, Scholl HP.

Br J Ophthalmol. 2008 Jul;92(7):941-5.PMID: 18577646 [PubMed - indexed for MEDLINE]Related articles

Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.

Charbel Issa P, Holz FG, Scholl HP.

Ophthalmology. 2007 Sep;114(9):1736-42.PMID: 17822979 [PubMed - indexed for MEDLINE]Related articles

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.

Retina. 2008 Oct;28(8):1053-60.PMID: 18779710 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.

Kovach JL, Rosenfeld PJ.

Retina. 2009 Jan;29(1):27-32.PMID: 18936721 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.PMID: 17151486 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab in the treatment of idiopathic macular telangiectasia.

Gamulescu MA, Walter A, Sachs H, Helbig H.

Graefes Arch Clin Exp Ophthalmol. 2008 Aug;246(8):1189-93. Epub 2008 Apr 2.PMID: 18386039 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.

Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS, Klancnik JM Jr, Fisher YL, Cooney MJ, Yannuzzi LA.

Retina. 2007 Apr-May;27(4):451-7.PMID: 17420697 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.

Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME; Pan-American Collaborative Retina Study Group.

Ophthalmology. 2007 Apr;114(4):743-50.PMID: 17398322 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Retina. 2007 Feb;27(2):141-9.PMID: 17290194 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ.

Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1241-7. Epub 2008 Jun 11.PMID: 18546006 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia.

Mandal S, Venkatesh P, Abbas Z, Vohra R, Garg S.

Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1825-9. Epub 2007 Mar 8.PMID: 17345090 [PubMed - indexed for MEDLINE]Related articles

Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Chung EJ, Roh MI, Kwon OW, Koh HJ.

Retina. 2008 Jul-Aug;28(7):957-63.PMID: 18698297 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.

Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL.

Retina. 2007 Apr-May;27(4):419-25.PMID: 17420692 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A.

Ophthalmology. 2006 Oct;113(10):1695.e1-15.PMID: 17011951 [PubMed - indexed for MEDLINE]Related articles

[Anti-VEGF treatment for retinal angiomatous proliferation]

Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A, Ulbig M.

Ophthalmologe. 2008 Sep;105(9):845-51. German. PMID: 18607601 [PubMed - indexed for MEDLINE]Related articles

Early bevacizumab treatment of central retinal vein occlusion.

Ferrara DC, Koizumi H, Spaide RF.

Am J Ophthalmol. 2007 Dec;144(6):864-71. Epub 2007 Oct 4.PMID: 17916320 [PubMed - indexed for MEDLINE]Related articles

Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.

Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, Evans T, Costa RA, Cardillo J; Pan-American Collaborative Retina Study Group (PACORES).

Retina. 2008 Feb;28(2):212-9.PMID: 18301025 [PubMed - indexed for MEDLINE]Related articles

Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.

Byeon SH, Kwon YA, Oh HS, Kim M, Kwon OW.

J Ocul Pharmacol Ther. 2007 Aug;23(4):387-94.PMID: 17803438 [PubMed - indexed for MEDLINE]Related articles

Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation.

Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1597-602. Epub 2007 Apr 17.PMID: 17437123 [PubMed - indexed for MEDLINE]Related articles